David Rossi

901 total citations
20 papers, 593 citations indexed

About

David Rossi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, David Rossi has authored 20 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in David Rossi's work include Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). David Rossi is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). David Rossi collaborates with scholars based in Italy and United States. David Rossi's co-authors include Giuseppe Coppola, Franco Lombardi, Alessandro Desideri, Dario Mantovani, Vincenzo Catalano, Paolo Giordani, Paolo Alessandroni, Francesco Graziano, Anna Maria Baldelli and Giammaria Fiorentini and has published in prestigious journals such as Journal of Clinical Oncology, The Oncologist and Histopathology.

In The Last Decade

David Rossi

20 papers receiving 572 citations

Peers

David Rossi

CCM

ONCOL

PRM

Juanni Gong China

Anders Christian Larsen Denmark

Angélique Da Silva France

Karol Nowak Poland

Xue Yu China

Arman Alimohammadi Austria

Wataru Shioyama Japan

Jean Chidiac France

Carol Zhao United States

Silvia Chiorrini Italy

Juanni Gong China

David Rossi

162 ×0.6

CCM

55 ×0.3

ONCOL

266 ×2.5

PRM

129 ×1.7

151 ×2.0

Citations per year, relative to David Rossi David Rossi (= 1×) peers Juanni Gong

Countries citing papers authored by David Rossi

Since Specialization

Citations

This map shows the geographic impact of David Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rossi more than expected).

Fields of papers citing papers by David Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rossi. The network helps show where David Rossi may publish in the future.

Co-authorship network of co-authors of David Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of David Rossi. A scholar is included among the top collaborators of David Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rossi. David Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, David. (2020). Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience. Lung Cancer. 145. 83–84. 6 indexed citations

Baker, Hayden P., et al.. (2020). Analysis of National Football League preseason injuries resulting in roster cuts: a retrospective review. Current Orthopaedic Practice. 32(1). 1–5. 1 indexed citations

Rossi, David, P. Lippe, Marco Rocchi, et al.. (2020). Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted. In Vivo. 34(5). 2687–2691. 2 indexed citations

Rossi, David, Donatella Sarti, Lara Malerba, et al.. (2016). Secondary Bone Marrow Malignancies after Adjuvant Chemotherapy for Breast Cancer: A Report of 2 Cases and a Review of the Literature. Tumori Journal. 102(2_suppl). S29–S31. 1 indexed citations

Fiorentini, Giammaria, Camillo Aliberti, Luca Mulazzani, et al.. (2014). Chemoembolization in colorectal liver metastases: the rebirth.. PubMed. 34(2). 575–84. 37 indexed citations

Catalano, Vincenzo, Renato Bisonni, Francesco Graziano, et al.. (2012). A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 16(3). 411–419. 28 indexed citations

Catalano, Vincenzo, Bruno Vincenzi, Paolo Giordani, et al.. (2012). Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study. Gastric Cancer. 15(4). 419–426. 2 indexed citations

Catalano, Vincenzo, Valerio Sisti, Daniele Spada, et al.. (2012). Assessment of the 7th edition of the AJCC classification and a proposal of a new classification in patients with gastric cancer undergoing D2 gastrectomy.. Journal of Clinical Oncology. 30(15_suppl). 4084–4084. 1 indexed citations

Ruzzo, Annamaria, Francesco Graziano, Bruno Vincenzi, et al.. (2012). High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease. The Oncologist. 17(6). 823–829. 68 indexed citations

10.

Catalano, Vincenzo, Pasquale Mellone, Alfredo D’Avino, et al.. (2011). HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer. Histopathology. 58(5). 669–678. 20 indexed citations

11.

Desideri, Alessandro, et al.. (2010). Progression From Paroxysmal to Persistent Atrial Fibrillation. Clinical Correlates and Prognosis. Default journal. 55. 725–731. 39 indexed citations

12.

Desideri, Alessandro, et al.. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation. Default journal. 137. 263–272. 256 indexed citations

13.

Rossi, David, Vincenzo Catalano, Paolo Alessandroni, et al.. (2010). Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial. Targeted Oncology. 5(4). 231–235. 12 indexed citations

14.

Rossi, David, Anna Maria Baldelli, Stefano Fedeli, et al.. (2008). Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer. Anti-Cancer Drugs. 19(7). 733–737. 27 indexed citations

15.

Rossi, David, Paolo Alessandroni, Vincenzo Catalano, et al.. (2008). Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study. Clinical Lung Cancer. 9(5). 280–284. 14 indexed citations

16.

Rossi, David, Vincenzo Catalano, Paolo Alessandroni, et al.. (2007). A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 8(6). 382–385. 13 indexed citations

17.

Rossi, David, Paolo Alessandroni, Vincenzo Catalano, et al.. (2007). Safety Profile and Activity of Lower Capecitabine Dose in Patients with Metastatic Breast Cancer. Clinical Breast Cancer. 7(11). 857–860. 27 indexed citations

18.

Rossi, David, Francesco Graziano, Paolo Alessandroni, et al.. (2004). Weekly Docetaxel as Second-Line Therapy in Non-Small Cell Lung Cancer: A Phase II Study. Tumori Journal. 90(1). 50–53. 9 indexed citations

19.

Cascinu, Stefano, Frank M. Graziano, Paolo Alessandroni, et al.. (1998). Different doses of pamidronate in patients with painful osteolytic bone metastases. Supportive Care in Cancer. 6(2). 139–143. 27 indexed citations

20.

Cascinu, Stefano, Paolo Alessandroni, David Rossi, et al.. (1996). Multimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer. Cancer Chemotherapy and Pharmacology. 38(4). 385–386. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact